Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Haebel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Chemical Information and Modeling|June 5, 2012
SAR matrices: automated extraction of information-rich SAR tables from large compound data setsAnne Mai Wassermann, Peter Haebel, Nils Weskamp, et al.
Biochemical and Biophysical Research Communications|November 7, 2006
Crystal structure of Bacillus subtilis S-adenosylmethionine:tRNA ribosyltransferase-isomeraseClemens Grimm, Ralf Ficner, Tanja Sgraja, et al.
Journal of Chemical Information and Modeling|August 19, 2022
BILN: A Human-Readable Line Notation for Complex PeptidesThomas Fox, Michael Bieler, Peter Haebel, et al.
Bioorganic & Medicinal Chemistry|September 11, 2004
Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amidesAndreas Mitsch, Pia Wissner, Katrin Silber, et al.
Molecular Metabolism|June 30, 2023
Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse modelMona Loeffler, Katarina Klepac, Angela Baljuls, et al.
Journal of Molecular Biology|April 17, 2007
Sulfate acts as phosphate analog on the monomeric catalytic fragment of the CPx-ATPase CopB from Sulfolobus solfataricusMathias Lübben, Jörn Güldenhaupt, Martin Zoltner, et al.
European Journal of Medicinal Chemistry|January 12, 2005
Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activityKatja Kettler, Jochen Wiesner, Katrin Silber, et al.
Diabetologia|October 15, 2025
Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse modelsEllen Vercalsteren, Dimitra Karampatsi, Maria Neicu, et al.
Scientific Reports|April 14, 2021
Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese miceHenrik H Hansen, Rikke V Grønlund, Tamara Baader-Pagler, et al.
Chemmedchem|May 13, 2008
Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarialsKatja Kohring, Jochen Wiesner, Mirko Altenkämper, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Chemical Information and Modeling|June 5, 2012
SAR matrices: automated extraction of information-rich SAR tables from large compound data setsAnne Mai Wassermann, Peter Haebel, Nils Weskamp, et al.
Biochemical and Biophysical Research Communications|November 7, 2006
Crystal structure of Bacillus subtilis S-adenosylmethionine:tRNA ribosyltransferase-isomeraseClemens Grimm, Ralf Ficner, Tanja Sgraja, et al.
Journal of Chemical Information and Modeling|August 19, 2022
BILN: A Human-Readable Line Notation for Complex PeptidesThomas Fox, Michael Bieler, Peter Haebel, et al.
Bioorganic & Medicinal Chemistry|September 11, 2004
Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amidesAndreas Mitsch, Pia Wissner, Katrin Silber, et al.
Molecular Metabolism|June 30, 2023
Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse modelMona Loeffler, Katarina Klepac, Angela Baljuls, et al.
Journal of Molecular Biology|April 17, 2007
Sulfate acts as phosphate analog on the monomeric catalytic fragment of the CPx-ATPase CopB from Sulfolobus solfataricusMathias Lübben, Jörn Güldenhaupt, Martin Zoltner, et al.
European Journal of Medicinal Chemistry|January 12, 2005
Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activityKatja Kettler, Jochen Wiesner, Katrin Silber, et al.
Diabetologia|October 15, 2025
Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse modelsEllen Vercalsteren, Dimitra Karampatsi, Maria Neicu, et al.
Scientific Reports|April 14, 2021
Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese miceHenrik H Hansen, Rikke V Grønlund, Tamara Baader-Pagler, et al.
Chemmedchem|May 13, 2008
Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarialsKatja Kohring, Jochen Wiesner, Mirko Altenkämper, et al.
Pageof 2